Mastodawn

The PATHWAYS trial for puberty blockers in young people is on hold. The MHRA wants to raise the minimum age from 10 to 14 due to safety concerns.

#PubertyBlockers, #ClinicalTrial, #MHRA, #ChildSafety, #GenderIncongruence

https://newsletter.tf/uk-puberty-blocker-trial-paused-for-young-people-due-to-safety-worries/

UK Puberty Blocker Trial Paused for Young People Due to Safety Worries

A UK clinical trial for puberty blockers for gender incongruence is paused. The MHRA has safety concerns about young participants, especially the minimum age.